Eight students from five universities spent eight weeks of their summer at Duke University as part of the

For most cancers, advances in genomics haven’t changed treatment strategies very much.

Durham, N.C. (July 8, 2021) – Xilis, Inc., a pioneering company using its MicroOrganoSphere (MOS) technology to guide precision therapy for cancer patients and accelerate drug

By Kate Robinson | Technology Networks: Drug Discovery

Here are summaries of a selection of the papers published by GCB faculty in May 2021:

The 2021 Summer Scholars Program in Genome Sciences and Medicine for Underrepresented Minority Underclassmen begins May 11 and will run through July 2.

Here are summaries of a selection of the papers published by GCB faculty in April 2021: